ID CELR2_MOUSE Reviewed; 2919 AA. AC Q9R0M0; A2AEE7; Q99K26; Q9Z2R4; DT 02-AUG-2002, integrated into UniProtKB/Swiss-Prot. DT 10-APR-2019, sequence version 3. DT 02-SEP-2026, entry version 201. DE RecName: Full=Cadherin EGF LAG seven-pass G-type receptor 2; DE AltName: Full=Flamingo homolog; DE Flags: Precursor; GN Name=Celsr2 {ECO:0000312|MGI:MGI:1858235}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=10490098; DOI=10.1016/s0092-8674(00)80046-x; RA Usui T., Shima Y., Shimada Y., Hirano S., Burgess R.W., Schwarz T.L., RA Takeichi M., Uemura T.; RT "Flamingo, a seven-pass transmembrane cadherin, regulates planar cell RT polarity under the control of frizzled."; RL Cell 98:585-595(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP PROTEIN SEQUENCE OF 158-170 AND 205-215, AND IDENTIFICATION BY MASS RP SPECTROMETRY. RC STRAIN=C57BL/6J; TISSUE=Brain; RA Lubec G., Kang S.U.; RL Submitted (APR-2007) to UniProtKB. RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1912-2795, AND TISSUE SPECIFICITY. RX PubMed=10790539; DOI=10.1007/s003350010073; RA Formstone C.J., Barclay J., Rees M., Little P.F.R.; RT "Chromosomal localization of Celsr2 and Celsr3 in the mouse; Celsr3 is a RT candidate for the tippy (tip) lethal mutant on chromosome 9."; RL Mamm. Genome 11:392-394(2000). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2013-2919 (ISOFORM 2). RC TISSUE=Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP DEVELOPMENTAL STAGE. RX PubMed=11850187; DOI=10.1016/s0925-4773(01)00623-2; RA Tissir F., De-Backer O., Goffinet A.M., Lambert de Rouvroit C.A.; RT "Developmental expression profiles of Celsr (Flamingo) genes in the RT mouse."; RL Mech. Dev. 112:157-160(2002). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, and Kidney; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Receptor that may have an important role in cell/cell CC signaling during nervous system formation. CC -!- SUBUNIT: Heterodimer of 2 chains generated by proteolytic processing; CC the large extracellular N-terminal fragment and the membrane-bound C- CC terminal fragment predominantly remain associated and non-covalently CC linked. {ECO:0000255|PROSITE-ProRule:PRU00098}. CC -!- INTERACTION: CC Q9R0M0; Q7T0S3: atp6ap2.S; Xeno; NbExp=2; IntAct=EBI-8294754, EBI-8294706; CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9R0M0-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9R0M0-2; Sequence=VSP_025765; CC -!- TISSUE SPECIFICITY: Expressed in the CNS and in the eye. CC {ECO:0000269|PubMed:10790539}. CC -!- DEVELOPMENTAL STAGE: Predominantly expressed in the developing CNS, the CC emerging dorsal root ganglia and cranial ganglia. In the CNS, CC expression is uniform along the rostrocaudal axis. During gastrulation, CC it is expressed within the anterior neural ectoderm. At 10 dpc, CC expression is strong in the ventricular zones (VZ) in all sectors of CC the brain, and lower in the marginal zones (MZ). Between 12 and 15 dpc, CC expression is prominent in the brain. It is strong in VZ, lower in MZ, CC except in telecephalic MZ where it is predominant. The intensity is CC higher in all VZ, and lower in differentiating fields than in VZ, CC except in the cerebral hemispheres, and to a lesser extent in the CC tectum and cerebellum. A weak expression is also observed in the fetal CC lungs, kidney and epithelia. In the newborn and postnatal stages, CC expression remains restricted to the VZ as well as in migrating and CC postmigratory cells throughout the brain. CC {ECO:0000269|PubMed:11850187}. CC -!- PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate CC and asparagine is (R) stereospecific within EGF domains. {ECO:0000250}. CC -!- PTM: Autoproteolytically processed at the GPS region of the GAIN-B CC domain; this cleavage modulates receptor activity. CC {ECO:0000255|PROSITE-ProRule:PRU00098}. CC -!- SIMILARITY: Belongs to the G protein-coupled receptor 2 family. LN-TM7 CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB028499; BAA84070.1; -; mRNA. DR EMBL; AF031573; AAC68837.1; -; mRNA. DR EMBL; AL671899; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL672200; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH466607; EDL01967.1; -; Genomic_DNA. DR EMBL; BC005499; AAH05499.1; -; mRNA. DR CCDS; CCDS17759.1; -. [Q9R0M0-1] DR RefSeq; NP_059088.2; NM_017392.4. [Q9R0M0-1] DR SMR; Q9R0M0; -. DR FunCoup; Q9R0M0; 1159. DR IntAct; Q9R0M0; 3. DR MINT; Q9R0M0; -. DR STRING; 10090.ENSMUSP00000088046; -. DR MEROPS; P02.006; -. DR MEROPS; P02.953; -. DR GlyConnect; Q9R0M0; 4 N-Linked glycans (5 sites). DR GlyCosmos; Q9R0M0; 17 sites, 4 glycans. DR GlyGen; Q9R0M0; 19 sites, 10 N-linked glycans (11 sites), 1 O-linked glycan (1 site). DR iPTMnet; Q9R0M0; -. DR PhosphoSitePlus; Q9R0M0; -. DR PaxDb; 10090-ENSMUSP00000088046; -. DR ProteomicsDB; 281578; -. [Q9R0M0-1] DR ProteomicsDB; 281579; -. [Q9R0M0-2] DR ProteomicsDB; 336635; -. DR Antibodypedia; 2940; 218 antibodies from 31 providers. DR DNASU; 53883; -. DR Ensembl; ENSMUST00000090558.11; ENSMUSP00000088046.4; ENSMUSG00000068740.15. [Q9R0M0-1] DR GeneID; 53883; -. DR KEGG; mmu:53883; -. DR UCSC; uc008qyx.1; mouse. DR AGR; MGI:1858235; -. DR CTD; 1952; -. DR MGI; MGI:1858235; Celsr2. DR VEuPathDB; HostDB:ENSMUSG00000068740; -. DR eggNOG; KOG4289; Eukaryota. DR GeneTree; ENSGT00940000157493; -. DR HOGENOM; CLU_000158_1_0_1; -. DR InParanoid; Q9R0M0; -. DR OMA; FTLYIVE; -. DR OrthoDB; 26203at2759; -. DR PhylomeDB; Q9R0M0; -. DR BioGRID-ORCS; 53883; 4 hits in 77 CRISPR screens. DR PRO; PR:Q9R0M0; -. DR Proteomes; UP000000589; Chromosome 3. DR RNAct; Q9R0M0; protein. DR Bgee; ENSMUSG00000068740; Expressed in skin of snout and 258 other cell types or tissues. DR ExpressionAtlas; Q9R0M0; baseline and differential. DR GO; GO:0005912; C:adherens junction; IBA:GO_Central. DR GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL. DR GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0004930; F:G protein-coupled receptor activity; IEA:InterPro. DR GO; GO:0007409; P:axonogenesis; IBA:GO_Central. DR GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; IBA:GO_Central. DR GO; GO:0033326; P:cerebrospinal fluid secretion; IGI:MGI. DR GO; GO:0060271; P:cilium assembly; IMP:MGI. DR GO; GO:0003341; P:cilium movement; IMP:MGI. DR GO; GO:0048813; P:dendrite morphogenesis; ISO:GO_Central. DR GO; GO:0007156; P:homophilic cell-cell adhesion; IDA:BHF-UCL. DR GO; GO:0021999; P:neural plate anterior/posterior regionalization; IDA:BHF-UCL. DR GO; GO:0001764; P:neuron migration; IMP:MGI. DR GO; GO:0022407; P:regulation of cell-cell adhesion; ISO:GO_Central. DR GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:BHF-UCL. DR GO; GO:0032880; P:regulation of protein localization; IMP:MGI. DR GO; GO:0021591; P:ventricular system development; IMP:MGI. DR GO; GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL. DR CDD; cd11304; Cadherin_repeat; 9. DR CDD; cd00054; EGF_CA; 4. DR CDD; cd00055; EGF_Lam; 1. DR CDD; cd00110; LamG; 2. DR FunFam; 2.10.25.10:FF:000011; Cadherin EGF LAG seven-pass G-type receptor; 1. DR FunFam; 2.60.40.60:FF:000013; Cadherin EGF LAG seven-pass G-type receptor; 1. DR FunFam; 1.20.1070.10:FF:000112; Cadherin EGF LAG seven-pass G-type receptor 2; 1. DR FunFam; 2.60.120.200:FF:000020; Cadherin EGF LAG seven-pass G-type receptor 2; 1. DR FunFam; 2.60.120.200:FF:000062; Cadherin EGF LAG seven-pass G-type receptor 2; 1. DR FunFam; 2.60.220.50:FF:000005; Cadherin EGF LAG seven-pass G-type receptor 2; 1. DR FunFam; 1.25.40.610:FF:000005; cadherin EGF LAG seven-pass G-type receptor 2; 1. DR FunFam; 2.10.25.10:FF:000156; cadherin EGF LAG seven-pass G-type receptor 2; 1. DR FunFam; 2.10.25.10:FF:000089; Cadherin EGF LAG seven-pass G-type receptor 3; 1. DR FunFam; 2.60.40.60:FF:000010; Cadherin EGF LAG seven-pass G-type receptor 3; 2. DR FunFam; 2.60.40.60:FF:000023; Cadherin EGF LAG seven-pass G-type receptor 3; 2. DR FunFam; 2.60.40.60:FF:000029; Cadherin EGF LAG seven-pass G-type receptor 3; 1. DR FunFam; 2.60.40.60:FF:000038; Cadherin EGF LAG seven-pass G-type receptor 3; 1. DR FunFam; 2.60.40.60:FF:000040; cadherin EGF LAG seven-pass G-type receptor 3; 1. DR FunFam; 2.10.25.10:FF:000113; Cadherin, EGF LAG seven-pass G-type receptor 3; 1. DR FunFam; 2.60.40.60:FF:000044; Cadherin, EGF LAG seven-pass G-type receptor 3; 1. DR FunFam; 4.10.1240.10:FF:000003; Putative cadherin EGF LAG seven-pass G-type receptor 2; 1. DR FunFam; 2.10.25.10:FF:000864; Y-linked cadherin EGF LAG seven-pass G-type receptor 2; 1. DR Gene3D; 1.25.40.610; -; 1. DR Gene3D; 2.60.120.200; -; 2. DR Gene3D; 2.60.220.50; -; 1. DR Gene3D; 2.60.40.60; Cadherins; 9. DR Gene3D; 4.10.1240.10; GPCR, family 2, extracellular hormone receptor domain; 1. DR Gene3D; 2.10.25.10; Laminin; 7. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR032471; AGRL2-4_GAIN_subdom_A. DR InterPro; IPR002126; Cadherin-like_dom. DR InterPro; IPR015919; Cadherin-like_sf. DR InterPro; IPR056286; Cadherin_CELSR1-3_9th. DR InterPro; IPR020894; Cadherin_CS. DR InterPro; IPR013320; ConA-like_dom_sf. DR InterPro; IPR000742; EGF. DR InterPro; IPR001881; EGF-like_Ca-bd_dom. DR InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site. DR InterPro; IPR057244; GAIN_B. DR InterPro; IPR046338; GAIN_dom_sf. DR InterPro; IPR017981; GPCR_2-like_7TM. DR InterPro; IPR036445; GPCR_2_extracell_dom_sf. DR InterPro; IPR001879; GPCR_2_extracellular_dom. DR InterPro; IPR000832; GPCR_2_secretin-like. DR InterPro; IPR000203; GPS. DR InterPro; IPR001791; Laminin_G. DR InterPro; IPR002049; LE_dom. DR PANTHER; PTHR24026:SF32; CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 2; 1. DR PANTHER; PTHR24026; FAT ATYPICAL CADHERIN-RELATED; 1. DR Pfam; PF00002; 7tm_2; 1. DR Pfam; PF00028; Cadherin; 8. DR Pfam; PF23592; Cadherin_CELSR2_9th; 1. DR Pfam; PF00008; EGF; 2. DR Pfam; PF00053; EGF_laminin; 1. DR Pfam; PF16489; GAIN; 1. DR Pfam; PF01825; GPS; 1. DR Pfam; PF02210; Laminin_G_2; 2. DR PRINTS; PR00205; CADHERIN. DR PRINTS; PR00249; GPCRSECRETIN. DR SMART; SM00112; CA; 9. DR SMART; SM00181; EGF; 6. DR SMART; SM00179; EGF_CA; 5. DR SMART; SM00180; EGF_Lam; 1. DR SMART; SM00303; GPS; 1. DR SMART; SM00008; HormR; 1. DR SMART; SM00282; LamG; 2. DR SUPFAM; SSF49313; Cadherin-like; 9. DR SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 2. DR SUPFAM; SSF57196; EGF/Laminin; 4. DR PROSITE; PS00010; ASX_HYDROXYL; 2. DR PROSITE; PS00232; CADHERIN_1; 7. DR PROSITE; PS50268; CADHERIN_2; 9. DR PROSITE; PS00022; EGF_1; 6. DR PROSITE; PS01186; EGF_2; 4. DR PROSITE; PS50026; EGF_3; 6. DR PROSITE; PS01248; EGF_LAM_1; 1. DR PROSITE; PS50027; EGF_LAM_2; 1. DR PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1. DR PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1. DR PROSITE; PS50221; GAIN_B; 1. DR PROSITE; PS50025; LAM_G_DOMAIN; 2. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Cell membrane; Developmental protein; KW Direct protein sequencing; Disulfide bond; EGF-like domain; KW G protein-coupled receptor; Glycoprotein; Hydroxylation; KW Laminin EGF-like domain; Membrane; Receptor; Reference proteome; Repeat; KW Signal; Transducer; Transmembrane; Transmembrane helix. FT SIGNAL 1..31 FT /evidence="ECO:0000255" FT CHAIN 32..2919 FT /note="Cadherin EGF LAG seven-pass G-type receptor 2" FT /id="PRO_0000012917" FT TOPO_DOM 32..2380 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 2381..2401 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 2402..2413 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 2414..2433 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 2434..2438 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 2439..2459 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 2460..2480 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 2481..2501 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 2502..2518 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 2519..2539 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 2540..2563 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 2564..2584 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 2585..2591 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 2592..2612 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 2613..2919 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 182..289 FT /note="Cadherin 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 290..399 FT /note="Cadherin 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 400..505 FT /note="Cadherin 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 506..610 FT /note="Cadherin 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 611..712 FT /note="Cadherin 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 713..815 FT /note="Cadherin 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 816..921 FT /note="Cadherin 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 922..1023 FT /note="Cadherin 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 1028..1146 FT /note="Cadherin 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 1228..1286 FT /note="EGF-like 1; atypical" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1288..1318 FT /note="EGF-like 2; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1328..1366 FT /note="EGF-like 3; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1367..1571 FT /note="Laminin G-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00122" FT DOMAIN 1574..1610 FT /note="EGF-like 4; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1614..1791 FT /note="Laminin G-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00122" FT DOMAIN 1787..1829 FT /note="EGF-like 5; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1830..1867 FT /note="EGF-like 6; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1883..1922 FT /note="EGF-like 7; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1924..1971 FT /note="Laminin EGF-like" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 2199..2369 FT /note="GAIN-B" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00098" FT REGION 156..194 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2216..2241 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2319..2369 FT /note="GPS" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00098" FT REGION 2690..2884 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 175..194 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2718..2730 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2791..2800 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2803..2815 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2857..2868 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT SITE 2356..2357 FT /note="Cleavage; by autolysis" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00098" FT MOD_RES 1591 FT /note="(3R)-3-hydroxyasparagine" FT /evidence="ECO:0000255" FT CARBOHYD 486 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 557 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 701 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1036 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1076 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1182 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1212 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1501 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1565 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1741 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1827 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1900 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2024 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2043 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2061 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2323 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2345 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 1292..1303 FT /evidence="ECO:0000250" FT DISULFID 1297..1312 FT /evidence="ECO:0000250" FT DISULFID 1314..1323 FT /evidence="ECO:0000250" FT DISULFID 1332..1343 FT /evidence="ECO:0000250" FT DISULFID 1337..1353 FT /evidence="ECO:0000250" FT DISULFID 1355..1365 FT /evidence="ECO:0000250" FT DISULFID 1545..1571 FT /evidence="ECO:0000250" FT DISULFID 1578..1589 FT /evidence="ECO:0000250" FT DISULFID 1583..1598 FT /evidence="ECO:0000250" FT DISULFID 1600..1609 FT /evidence="ECO:0000250" FT DISULFID 1791..1802 FT /evidence="ECO:0000250" FT DISULFID 1797..1817 FT /evidence="ECO:0000250" FT DISULFID 1819..1828 FT /evidence="ECO:0000250" FT DISULFID 1832..1843 FT /evidence="ECO:0000250" FT DISULFID 1837..1855 FT /evidence="ECO:0000250" FT DISULFID 1857..1866 FT /evidence="ECO:0000250" FT DISULFID 1887..1899 FT /evidence="ECO:0000250" FT DISULFID 1889..1906 FT /evidence="ECO:0000250" FT DISULFID 1908..1921 FT /evidence="ECO:0000250" FT DISULFID 1924..1936 FT /evidence="ECO:0000250" FT DISULFID 1926..1943 FT /evidence="ECO:0000250" FT DISULFID 1945..1954 FT /evidence="ECO:0000250" FT DISULFID 1957..1969 FT /evidence="ECO:0000250" FT DISULFID 2319..2351 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00098" FT DISULFID 2339..2353 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00098" FT VAR_SEQ 2912..2919 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_025765" FT CONFLICT 3 FT /note="S -> T (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 334 FT /note="G -> D (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 638 FT /note="D -> H (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 721 FT /note="V -> G (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 762 FT /note="A -> G (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 823 FT /note="S -> T (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 838 FT /note="S -> L (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 914 FT /note="V -> G (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1222 FT /note="Q -> K (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1268 FT /note="P -> L (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1280 FT /note="F -> L (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1296 FT /note="P -> T (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1315..1317 FT /note="LDG -> RGC (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1351 FT /note="F -> I (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1359 FT /note="D -> H (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1376 FT /note="S -> P (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1384 FT /note="R -> H (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1595 FT /note="A -> T (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1631 FT /note="S -> Y (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1641 FT /note="S -> N (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1674..1677 FT /note="VLSV -> RLSM (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1688 FT /note="R -> H (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1710 FT /note="G -> R (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1720 FT /note="D -> N (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1725 FT /note="K -> T (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1774..1775 FT /note="IS -> VH (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1793 FT /note="W -> L (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1808 FT /note="C -> Y (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1813 FT /note="D -> N (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 1911 FT /note="N -> K (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 2198 FT /note="L -> V (in Ref. 5; AAC68837 and 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 2282 FT /note="V -> A (in Ref. 5; AAC68837 and 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 2534 FT /note="S -> R (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 2570 FT /note="L -> R (in Ref. 5; AAC68837)" FT /evidence="ECO:0000305" FT CONFLICT 2638 FT /note="S -> Y (in Ref. 5; AAC68837 and 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 2760 FT /note="L -> C (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 2795 FT /note="K -> R (in Ref. 5; AAC68837)" FT /evidence="ECO:0000305" FT CONFLICT 2802 FT /note="P -> A (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" FT CONFLICT 2899 FT /note="K -> N (in Ref. 1; BAA84070)" FT /evidence="ECO:0000305" SQ SEQUENCE 2919 AA; 316986 MW; A8F35C88C5808300 CRC64; MRSRAASAPL PTPLLPLLLL LLLLPPSPLL GDQVGPCRSL GSGGRSSSGA CAPVGWLCPA SASNLWLYTS RCRESGIELT GHLVPHHDGL RVWCPESGAH IPLPPSSEGC PWSCRLLGIG GHLSPQGTLT LPEEHPCLKA PRLRCQSCKL AQAPGLRAGE GSPEESLGGR RKRNVNTAPQ FQPPSYQATV PENQPAGTSV ASLRAIDPDE GEAGRLEYTM DALFDSRSNH FFSLDPITGV VTTAEELDRE TKSTHVFRVT AQDHGMPRRS ALATLTILVT DTNDHDPVFE QQEYKESLRE NLEVGYEVLT VRATDGDAPP NANILYRLLE GAGGSPSDAF EIDPRSGVIR TRGPVDREEV ESYKLTVEAS DQGRDPGPRS STAIVFLSVE DDNDNAPQFS EKRYVVQVRE DVTPGAPVLR VTASDRDKGS NALVHYSIMS GNARGQFYLD AQTGALDVVS PLDYETTKEY TLRIRAQDGG RPPLSNVSGL VTVQVLDIND NAPIFVSTPF QATVLESVPL GYLVLHVQAI DADAGDNARL EYSLAGVGHD FPFTINNGTG WISVAAELDR EEVDFYSFGV EARDHGTPAL TASASVSVTI LDVNDNNPTF TQPEYTVRLN EDAAVGTSVV TVSAVDRDAH SVITYQITSG NTRNRFSITS QSGGGLVSLA LPLDYKLERQ YVLAVTASDG TRQDTAQIVV NVTDANTHRP VFQSSHYTVN VNEDRPAGTT VVLISATDED TGENARITYF MEDSIPQFRI DADTGAVTTQ AELDYEDQVS YTLAITARDN GIPQKSDTTY LEILVNDVND NAPQFLRDSY QGSVYEDVPP FTSVLQISAT DRDSGLNGRV FYTFQGGDDG DGDFIVESTS GIVRTLRRLD RENVAQYVLR AYAVDKGMPP ARTPMEVTVT VLDVNDNPPV FEQDEFDVFV EENSPIGLAV ARVTATDPDE GTNAQIMYQI VEGNIPEVFQ LDIFSGELTA LVDLDYEDRP EYVLVIQATS APLVSRATVH VRLLDRNDNP PVLGNFEILF NNYVTNRSSS FPGGAIGRVP AHDPDISDSL TYSFERGNEL SLVLLNASTG ELRLSRALDN NRPLEAIMSV LVSDGVHSVT AQCSLRVTII TDEMLTHSIT LRLEDMSPER FLSPLLGLFI QAVAATLATP PDHVVVFNVQ RDTDAPGGHI LNVSLSVGQP PGPGGGPPFL PSEDLQERLY LNRSLLTAIS AQRVLPFDDN ICLREPCENY MRCVSVLRFD SSAPFIASSS VLFRPIHPVG GLRCRCPPGF TGDYCETEVD LCYSRPCGPH GRCRSREGGY TCLCLDGYTG EHCEASTHSG RCTPGVCKNG GTCVNLLVGG FKCDCPSGDF EKPFCQVTTR SFPARSFITF RGLRQRFHFT LALSFATKER NGLLLYNGRF NEKHDFVALE VIQEQVQLTF SAGESTTTVS PFVPGGVSDG QWHTVQLKYY NKPLLGQTGL PQGPSEQKVA VVSVDGCDTG VALRFGAMLG NYSCAAQGTQ GGSKKSLDLT GPLLLGGVPD LPESFPVRMR HFVGCMKDLQ VDSRHIDMAD FIANNGTVPG CPTKKIVCDS SICHNGGTCV NQWNAFSCEC PLGFGGKSCA QEMANPQRFL GSSLVAWHGL SLPISQPWHL SLMFRTRQAD GVLLQAVTRG RSTITLQLRA GHVVLSVEGT GLQASSLRLE PGRANDGDWH HAQLALGASG GPGHAILSFD YGQQKAEGNL GPRLHGLHLS NITVGGVPGP ASGVARGFRG CLQGVRVSET PEGISSLDPS RGESINVEPG CSWPDPCDSN PCPTNSYCSN DWDSYSCSCV LGYYGDNCTN VCDLNPCEHQ SVCTRKPNTP HGYICECLPN YLGPYCETRI DQPCPRGWWG HPTCGPCNCD VSKGFDPDCN KTSGECHCKE NHYRPPGSPT CLLCDCYPTG SLSRVCDPED GQCPCKPGVI GRQCDRCDNP FAEVTTNGCE VNYDSCPRAI EAGIWWPRTR FGLPAAAPCP KGSFGTAVRH CDEHRGWLPP NLFNCTSVTF SELKGFAERL QRNESGLDSG RSQRLALLLR NATQHTSGYF GSDVKVAYQL ATRLLAHESA QRGFGLSATQ DVHFTENLLR VGSALLDAAN KRHWELIQQT EGGTAWLLQH YEAYASALAQ NMRHTYLSPF TIVTPNIVIS VVRLDKGNFA GTKLPRYEAL RGERPPDLET TVILPESVFR EMPSMVRSAG PGEAQETEEL ARRQRRHPEL SQGEAVASVI IYHTLAGLLP HNYDPDKRSL RVPKRPVINT PVVSISVHDD EELLPRALDK PVTVQFRLLE TEERTKPICV FWNHSILVSG TGGWSARGCE VVFRNESHVS CQCNHMTSFA VLMDMSRREN GEILPLKTLT YVALGVTLAA LMLTFLFLTL LRALRSNQHG IRRNLTAALG LAQLVFLLGI NQADLPFACT VIAILLHFLY LCTFSWALLE ALHLYRALTE VRDVNASPMR FYYMLGWGVP AFITGLAVGL DPEGYGNPDF CWLSVYDTLI WSFAGPVAFA VSMSVFLYIL SARASCAAQR QGFEKKGPVS GLRSSFTVLL LLSATWLLAL LSVNSDTLLF HYLFAACNCV QGPFIFLSYV VLSKEVRKAL KFACSRKPSP DPALTTKSTL TSSYNCPSPY ADGRLYQPYG DSAGSLHSAS RSGKSQPSYI PFLLREESTL NPGQVPPGLG DPSGLFLEGQ AQQHDPDTDS DSDLSLEDDQ SGSYASTHSS DSEEEEEEAA FPGEQGWDSL LGPGAERLPL HSTPKDGGPG SGKVPWLGDF GTTTKENSGS GPLEERPREN GDALTREGSL GPLPGPSTQP HKGILKKKCL PTISEKSSLL RLPLEQGTGS SRGSSISEGS RHGPPPRPPP RQSLQEQLNG VMPVAMSIKA GTVDEDSSGS EFLFFNFLH //